Oncomatryx announces 15m euros funding to conduct clinical trials
Company at the forefront of developing personalised treatments against invasive cancer has raised 15m euros to conduct clinical trials
Read More
Tag: Oncomatryx
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
